000 | 01133nas a22002417a 4500 | ||
---|---|---|---|
003 | OSt | ||
005 | 20210316120812.0 | ||
006 | m|||||r|||| 00| 0 | ||
007 | ta | ||
008 | 171219t2018 sp ||||| |||| 00| 0 spa | | ||
022 | _a1055-3207 | ||
040 | _cSalus Infirmorum | ||
245 | 0 | 0 |
_aAnatomy and Breast Cancer Staging: Is It Still Relevant? / _cJennifer K. Plichta, Brittany M. Campbell, Elizabeth A. Mittendorf, E. Shelley Hwang |
500 | _aPDF en biblioteca | ||
504 | _aBibliografía: p. 65-67 | ||
520 | 8 | _aAnatomic staging for breast cancer continues to provide prognostic information relevant to patients and clinicians. Prognostic staging for breast cancer now includes both anatomic factors and tumorspecific factors, such as receptor status and genomic profiles. By incorporating tumor biology, the new staging system will likely improve the future discrimination of prognosis between tumor stages | |
653 | 1 | 4 | _aBreast cancer |
653 | 1 | 4 | _aStaging |
653 | 1 | 4 | _aPrognosis |
653 | 1 | 4 | _aBiomarkers |
773 |
_g-- 2018, v 27, p. 51–67 _tSurgical Oncology Clinics of North America |
||
942 |
_2udc _cARTÍCULO |
||
999 |
_c12951 _d12951 |